Parker Institute to Showcase Advances in Cancer Vaccines, Cell Therapies, and Next-Generation Immunotherapies at SITC 2026
Parker Institute/LinkedIn

Parker Institute to Showcase Advances in Cancer Vaccines, Cell Therapies, and Next-Generation Immunotherapies at SITC 2026

Parker Institute shared on LinkedIn:

“Parker Institute is heading to SITC 2026!

Parker leaders, investigators, and collaborators will contribute to 32 presentations, posters, and sessions at the 41st Annual Meeting of the Society for Immunotherapy of Cancer (SITC), November 4-8 in Phoenix, showcasing advances in cancer vaccines, cell therapies, and next-generation immunotherapies.

Congratulations to Catherine J. Wu, Parker Institute Co-Director at Dana-Farber Cancer Institute, who will receive SITC’s 2026 Richard V. Smalley Memorial Award and Lectureship and deliver a keynote address on personalized cancer vaccines.

Catherine J. Wu

Catherine J. Wu/dana-farber.org

We look forward to sharing the latest research from across our network!

Explore what the Parker Institute network will be presenting here: Parker Institute Showcases Latest Advances in Immunotherapy at SITC 2026 Annual Meeting.”

Other articles about SITC 2026 and cancer vaccines on OncoDaily.